-
Keros Therapeutics (NASDAQ:KROS) Price Target Lowered to $44.00 at Scotiabank
Source: Buzz FX / 14 Dec 2024 17:06:11 America/New_York
Keros Therapeutics (NASDAQ:KROS) Price Target Lowered to $44.00 at Scotiabank Written by MarketBeat December 14, 2024 Share Link copied to clipboard. Keros Therapeutics ( NASDAQ:KROS - Get Free Report ) had its price target decreased by equ
Read more...